Lifeward Inc.

golifeward.com ; alterg.com

Formerly Argo Medical, ReWalk Robotics

High-Tech Company
Public Company

(NASDAQ GM: LFWD)

Graduated from: TechnionSeed

TECH VERTICALS

Assistive Technology, Robotics Biomechanics, Healthtech, Life Sciences, Medical Devices, MedTech, Wearables

General Data

Sector	Medical Devices
Company Stage:	Revenue Growth
Established	2001
Number of Employees	80
Employees in Israel	20
Reg. Number:	abCDe

DESCRIPTION

Lifeward designs, develops, and commercializes life-changing solutions that span the continuum of care in physical rehabilitation and recovery, delivering proven functional and health benefits in clinical settings as well as in the home and community. The company's mission is to drive innovation to change the lives of individuals with physical limitations or disabilities. Lifeward are committed to delivering groundbreaking solutions that empower individuals to do what they love. The Lifeward portfolio features innovative products including the ReWalk Exoskeleton, the AlterG Anti-Gravity System, the ReStore Exo-Suit, and the MyoCycle FES System.

TECHNOLOGY

Exoskeleton Technology, Robotics, Anti-Gravity Systems.

Products and Phases

Product	Phase
ReWalk® Personal Exoskeleton	FDA Approved CE Approved
The ReWalk Personal Exoskeleton offers patients with spinal cord injuries (SCI) a new level of independence with life-changing robotics. It is used as part of a home-based functional ambulation program to elevate the health and quality of life for individuals with spinal cord injury.
AlterG® Anti-Gravity Treadmill™	FDA Approved CE Approved
The AlterG® Anti-Gravity Treadmill features patented, NASA Differential Air Pressure (DAP) technology, a precise air calibration system, based on the user’s actual body weight. Using a pressurized air chamber to uniformly reduce gravitational load and body weight in precise 1% increments, AlterG enables patients and athletes to move unrestricted and pain-free – restoring and building muscle strength, range of motion, balance, function, and fitness.
ReStore® Exo-Suit	FDA Approved CE Approved
The ReStore Exo-Suit offers a revolutionary, robotic gait training solution to promote restoration of functional walking patterns post-stroke. It is specifically designed for use in rehabilitation settings with individuals suffering from hemiparesis.

ESTIMATED ANNUAL SALES

Year	Amount
2024	500
2023	490
2022	480
2021	470
2020	460
2019	450
2018	440
2017	430
2016	420
2015	410
2014	400
2013	390
2012	380

	TARGET MARKETS
	Rehabilitation Centers, Physical Therapy Clinics, Individuals with spinal cord injuries.

	BUSINESS MODEL
	B2C

COMPETITORS

Berkeley Bionics (eLegs) , Rex Bionics

SERVICE PROVIDERS

Company Name	Type
abC Defghij	Investment Bank

REMARKS

Date	Remark
13/01/2026	Lifeward has entered into a transformative strategic partnership with Oramed Pharmaceuticals Inc. (Nasdaq: ORMP). The transaction includes Lifeward integrating Oramed's proprietary protein oral delivery (POD) technology and Oramed acquiring up to a 49.99% equity ownership in Lifeward. The investment structure provides Lifeward with access to up to approximately $47m of capital through equity, convertible notes, milestone-based funding, and warrant coverage. 25/03/2026: Lifeward closed on the agreement, purchased the POD technology and received $10m out of the potential $47m from Ormaed and certain other investors.
	Lifeward is the U.S. distributor of MYOLYN Functional Electrical Stimulation (FES) bikes.

CONTACT INFO

Expand / Collapse All

Main Address: Marlborough, United States

Address	200 Donald Lynch Boulevard
City	Marlborough
State/Province	MA
Country	United States
Zip	01752

Contact Person	abC Defghij
Contact E-Mail	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

Branch Address: Yoqneam Ilit, Israel

Address	3 Hatnufa St. Kochav Yokneam Building, Fl. 6
POB	161
City	Yoqneam Ilit
Country	Israel
Zip	2069203

Contact Person	abC Defghij
Contact E-Mail	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

Branch Address: Berlin, Germany

Address	15 Leipziger Platz
City	Berlin
Country	Germany
Zip	10117

Contact Person	abC Defghij
Contact E-Mail	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

	MANAGEMENT

Key Executive

Name	Title	Previous Position
Mr. Mark Grant	CEO & President
Mr. Almog Adar	CFO
Ms. Mela Ikanovic	Deputy General Manager & VP, International Sales
Ms. Miri Pariente	VP, Operations, Regulatory & Quality
Ms. Judy Kula	VP, Customer Service, Human Resources & Business Affairs
Ms. Kathleen O'Donnell	VP, Marketing & New Business Development
Ms. Jeannine Lynch	VP, Strategy & Market Access
Mr. David Hexner	VP, R&D
Dr. Amit Goffer	Founder	Odin (CEO & President)

	BOARD

Board

Member	Title	Affiliation
abC Defghij	Chairman	EVP, Fresenius Medical Care
abC Defghij	Board Member	Co-CEO & President, Lifeward
abC Defghij	Board Member	Former Founder & President, Neocure Group LLC
abC Defghij	Board Member	CEO, BrainsWay
abC Defghij	Board Member	CFO & Treasurer, Lantheus Holdings Inc.
abC Defghij	Board Member	CEO, Numotion
abC Defghij	External Director	Director, EXA Corporation

Public Offerings

Deal Date	Type of Offering	Exchange	Amount Raise	Valuation	Remarks
Jun. 25, 2025	Ninth Public Offering	NASDAQ GM	abCDe	abCDe
Jan. 07, 2025	Eighth Public Offering	NASDAQ GM	abCDe	abCDe	Registered Direct Offering.
Jul. 06, 2020	Seventh Public Offering	NASDAQ GM	abCDe	abCDe	Registered Direct Offering.
Feb. 10, 2020	Sixth Public Offering	NASDAQ GM	abCDe	abCDe
Jun. 12, 2019	Fifth Public Offering	NASDAQ GM	abCDe	abCDe	Registered Direct Offering
Apr. 05, 2019	Fourth Public Offering	NASDAQ GM	abCDe	abCDe	Registered Direct Offering
Nov. 27, 2017	Third Public Offering	NASDAQ GM	abCDe	abCDe
Oct. 31, 2016	Second Public Offering	NASDAQ GM	abCDe	abCDe
Sep. 12, 2014	IPO	NASDAQ GM	abCDe	abCDe

	FINANCIAL ROUNDS

Total Capital Raised
abCDe

Financial Rounds

Numbers of Investors

Expand / Collapse All

Round

Date

Stage

Amount

Valuation

PIPE

Mar. 25, 2026

Revenue Growth

abCDe

PIPE

Feb. 23, 2021

Initial Revenues

abCDe

PIPE

Dec. 03, 2020

Initial Revenues

abCDe

PIPE

Jun. 05, 2019

Initial Revenues

abCDe

PIPE

Mar. 08, 2018

Initial Revenues

abCDe

Venture Lending

Jan. 04, 2016

Initial Revenues

abCDe

Fourth Round

Jul. 14, 2014

Initial Revenues

abCDe

Venture Lending

Jun. 01, 2014

R&D

abCDe

Third Round

Jul. 27, 2011

Initial Revenues

abCDe

Second Round

Nov. 02, 2009

R&D

abCDe

First Round

Apr. 01, 2006

R&D

abCDe

Seed

Oct. 01, 2003

Seed

abCDe

	R&D Grants

Expand / Collapse All

Round

Date

Stage

Amount

Remarks

R&D Grant

May. 01, 2024

Revenue Growth

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Government Agency	abCDe

R&D Grant

Mar. 01, 2022

Initial Revenues

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Government Agency	abCDe

R&D Grant

Dec. 11, 2008

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij*	Bi-National Fund	abCDe	Co-op with Allied Orthotics & Prosthetics (NJ)

R&D Grant

Oct. 01, 2003

Seed

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	R&D Support Program	abCDe

	Acquisitions made by Lifeward

Acquired Company	Sector	Date	Amount	Remarks
abC Defghij	Medica...	Aug. 08, 2023	abCDe

Last Updated:	abCDe
IVC Number:	abCDe